Tzahi Neuman, M.D, MHA

Senior pathologist, Head of GU unit and predictive biomarkers.

Education

• 1994-1997: B.Msc., Hebrew university, Jerusalem, Israel
• 1998-2000: M.D, Hebrew university, Jerusalem, Israel
• 2010-2011: M.H.A., Ben Gurion University, Be’er Sheva, Israel

Occupation
• 2002-2006 Mandatory military service, as a medical doctor
• 2006 – 2012 Pathology residency, HMC
• 2013 – 2014 Fellow, GU pathology, Fox Chase Cancer Center –Temple University, Philadelphia, PA, USA.
• 2015 – current Senior pathologist, HMC.
• 2021- current Head-GU unit & predictive biomarkers service, HMC
• 2022-current Deputy head- Dep. Of pathology, HMC, Israel

Research areas
• Biomarkers
• GU pathology
• Health Economics

Special and relevant functions
• 2018- Israeli member in an EU COST action
• 2018-2020: Member, Biomarkers in IO: EMEAC MSD Regional Advisory Board
• 2020-current: Member, committee for accreditation for pathological departments, the Israeli medical association
• 2022-current: Israel association of pathologists, secretary

Number of publications
• Involved in over 38 scientific papers in national and international academic journals
• One book chapter and one book editing

Prizes & awards
• 07/2010 “Award of Excellence in Clinical Work”
• 07/2010“ “Best Resident of the HMC
• 04/2013 Nominated as an APF fellow
• 05/2013 Claire and Emanuel G. Rosenblatt Fellowship (25K$)
• 04/2018 “Israeli Ministry of Health Prize”, for Personalized Medicine (research and innovation grant- 500K NIS)
• 11/2018 “Best Practice in Personalized Medicine” Award- ICPerMed (Travel grant- 1,500 Euro)

Scroll to Top